ALKERMES | 销售毛利

股票价格

30.23

每天变化

-0.50 -1.63%

每月一次

-10.83%

每年

-11.94%

Q1 预测

30.94

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 4.97B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

USD 19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	销售毛利	更改		日
AbbVie	USD 10.47B		605M	2025-09
Acadia Pharmaceuticals	USD 257.76M		778K	2025-12
ALKERMES	USD 338.34M		72.51M	2025-12
Amgen	USD 6.48B		307M	2025-09
Biogen	USD 1.65B		34.6M	2025-12
BioMarin Pharmaceutical	USD 713.01M		81.81M	2025-12
Bristol-Myers Squibb	USD 8.79B		110M	2025-09
Coherus Biosciences	USD 4.95M		15.34M	2025-03
Eli Lilly	USD 14.59B		1.48B	2025-09
Gilead Sciences	USD 6.31B		106M	2025-12
Heron Therapeutics	USD 23.35M		1.6M	2024-09
Ionis Pharmaceuticals	USD 195M		40M	2025-12
J&J	USD 16.6B		118M	2025-12
Merck	USD 13.42B		431M	2025-09
Minerva Neurosciences	-4.27M		26.79M	2024-12
Nektar Therapeutics	USD 13.75M		650K	2024-06
Neurocrine Biosciences	USD 787.9M		7M	2025-12
Otsuka Holdings	JPY 457.41B		28.26B	2025-12
Pfizer	USD 3.54B		7.61B	2025-09
Regeneron Pharmaceuticals	USD 3.3B		67M	2025-12
Vertex Pharmaceuticals	USD 2.72B		62.4M	2025-12

ALKERMES 销售毛利 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.